Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 28
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Rocky Intertidal Citizen Science

Monitoring the vital signs of our rocky intertidal community is critical to managing and understanding these...

A conservation comic book: Involving Rwandan children in saving endangered Grey Crowned Cranes

Grey Crowned Cranes are now classified as ‘endangered’ and their population is fast declining so if we don’t...

Backer Badge Funded